Akihiro Funakoshi - Concepedia

Author

Akihiro Funakoshi

National Hospital Organization Kyushu Cancer Center

Also Known As

A Funakoshi, AKIHIRO FUNAKOSHI, Akihiro FUNAKOSHI, Akihiro Funakoshi, FUNAKOSHI AKIHIRO, Funakoshi Akihiro

289

Publications

5.9K

Citations

H-Index

131

Concepts

All Affiliations

National Hospital Organization Kyushu Cancer Center Tokyo Metropolitan Institute of Gerontology Kyushu University Fukuoka University Kurume University

About

Akihiro Funakoshi is an author at National Hospital Organization Kyushu Cancer Center specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	81	3.6K
2	Health Sciences	13	16	384
3	Social Sciences	3	3	86
4	Natural Sciences	2	2	37
5	Public Health	1	1	13

Akihiro Funakoshi

128

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda, Journal of Clinical Oncology	2013	624
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study Hedy L. Kindler, Tatsuya Ioka, D. J. Richel, The Lancet Oncology Gemcitabine Versus PlaceboOncologyPancreatic CancerGastrointestinal OncologyPharmacology	2011	393
Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats Soichi Takiguchi, Yutaka Takata, Akihiro Funakoshi, Gene Signal TransductionMolecular PhysiologyOletf RatsReceptor (Biochemistry)Pathology	1997	172
A late phase II study of S-1 for metastatic pancreatic cancer Takuji Okusaka, Akihiro Funakoshi, Junji Furuse, Cancer Chemotherapy and Pharmacology Pancreatic CancerGastrointestinal OncologyMedicinePathologyMetastatic Pancreatic Cancer	2007	169
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Takuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, Cancer Chemotherapy and Pharmacology OncologyGastrointestinal OncologyMedicineBiliary CancerSingle-agent Gemcitabine	2005	150
Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer Makoto Shinoto, Shigeru Yamada, Kotaro Terashima, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation MedicineConcurrent GemcitabineRadiation TherapyPancreatic Cancer	2015	147
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study Junji Furuse, Takuji Okusaka, Narikazu Boku, Cancer Chemotherapy and Pharmacology S-1 MonotherapySurgical OncologyGastrointestinal OncologyMedicineBiliary Cancer	2008	146
A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer Masayuki Imamura, Ryuichiro Doi, Toshihide Imaizumi, Surgery Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineInvasive Pancreatic Cancer	2004	124
Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial Ryuichiro Doi, Masayuki Imamura, Ryo Hosotani, Surgery Today Surgical OncologySurgery Versus RadiochemotherapyPancreatic CancerMedicineInvasive Pancreatic Cancer	2008	118
Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: Effect of metoclopramide Sami R. Achem-Karam, Akihiro Funakoshi, Aaron I. Vinik, Gastroenterology MedicineInsulin ManagementDiabetesPhysiologyDiabetic Gastroparesis	1985	116

Page 1